PTI News and Press, Yumanity Therapeutics Inc Com From 12/27/19

Will These Penny Stocks Break to New Highs This Week? The stock market has been in breakout mode this week as the Santa Claus rally continued to push stocks higher on Thursday. The NASDAQ managed to break a new, all-time high and other markets around the world also saw big surges in trading mo...

Gainers:  CLPS (NASDAQ: CLPS )  +68% . More news on: CLPS Incorporation, Microbot Medical Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...

Soleno Therapeutics (NASDAQ: SLNO ) +15% . More news on: Soleno Therapeutics, Inc., Proteostasis Therapeutics, Inc., Microbot Medical Inc., Stocks on the move, Read more ...

Intra-Cellular Therapies (NASDAQ: ITCI ) +89%   after Caplyta approved by FDA. More news on: Intra-Cellular Therapies, Inc., Cincinnati Bell Inc., Seadrill Limited, Stocks on the move, Read more ...

Gainers: Southwest Georgia Financial (NYSEMKT: SGB )  +48% . More news on: Southwest Georgia Financial Corporation, Rite Aid Corporation, Paratek Pharmaceuticals, Inc., Stocks on the move, Read more ...

Gainers:  Kaixin Auto (NASDAQ: KXIN ) +32% . More news on: Kaixin Auto Holdings, NantKwest, Inc., Renewable Energy Group, Inc., Stocks on the move, Read more ...

Proteostasis Therapeutics (NASDAQ: PTI )  -37%  on mixed results in mid-stage CF study. More news on: Proteostasis Therapeutics, Inc., MEI Pharma, Inc., VistaGen Therapeutics, Inc., Stocks on the move, Read more ...

Proteostasis Therapeutics (NASDAQ: PTI ) slumps  34%  premarket on robust volume on the heels of topline results from a Phase 2 clinical trial evaluating its CFTR modulator combinations in cystic fibrosis (CF) patients. More news on: Proteostasis Therapeutics, Inc., Healthcar...

BOSTON , Dec. 17, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced positive topline results from the Com...

Screen capture via Acadia's website . Acadia And Proteostasis: Risk On? Since June of 2017, I have presented my system's top 10 names to my Marketplace subscribers each week. So far, we have full six-month performance numbers for 106 of those top names cohorts, and they have outperforme...